Eswatini vs Mozambique: Hepatitis B surface antigen (HBsAg) prevalence
Eswatini
1.2%
in 2024
Mozambique
1.1%
in 2024
Eswatini rank
25th
Mozambique rank
26th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Eswatini
- Mozambique
How they compare
Eswatini currently reports 1.2% against 1.1% in Mozambique, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Mozambique's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Mozambique ahead.
Eswatini ranks 25th and Mozambique ranks 26th of 194 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and Mozambique in 1.
Head to head by decade
| Decade | Eswatini | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.5% | 0.0% | Mozambique |
| 2020s | 1.4% | 1.0% | 0.4% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Eswatini or Mozambique?
- Eswatini, at 1.2% against 1.1% in Mozambique as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Eswatini and Mozambique?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Mozambique?
- 10 years are reported by both, from 2015 to 2024.
- How do Eswatini and Mozambique rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Eswatini ranks 25th and Mozambique ranks 26th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.